U.S. District Court Decides That Isolated Genes Cannot Be Patented

April 01, 2010

Tags:

Advertising and Marketing Intellectual Property Intellectual Property Litigation Life Sciences Patents

Related Expertise

Related Insights

Federal Court of Appeal breathes new life into “reverse” class actions
La Cour d’appel fédérale donne un nouvel élan aux recours collectifs inversés
“This Court does not sign blank cheques”: Federal Court of Appeal reverses Canada’s Patented Medicine Prices Review Board, restricting Board’s price control mandate
Déjà vu: Another delay in implementation of Canada’s PMPRB Regulations
Changes coming to patent examination in Canada

Back